Table 3.
Factors influencing the correlation between baseline levels of hs-TnT and hs-CRP at baseline and measures of plaque progression.
| Adjustment for | Correlation of hs-CRP with
|
Correlation of hs-TnT with
|
||||||
|---|---|---|---|---|---|---|---|---|
| Overall CAD change
|
Overall CAD change
|
New calcified plaque
|
Change of plaque morphology
|
|||||
| r | p | r | p | r | p | r | p | |
| Baseline plaque | 0.38 | .007 | 0.27 | .06 | 0.27 | .06 | 0.27 | .06 |
| LV mass | 0.37 | .008 | 0.29 | .04 | 0.31 | .04 | 0.29 | .04 |
| Baseline FRS | 0.41 | .003 | 0.30 | .04 | 0.31 | .03 | 0.34 | .02 |
| ACS at index hospitalization | 0.42 | .002 | 0.23 | .10 | 0.26 | .07 | 0.24 | .08 |
CAD, coronary artery disease; FRS, Framingham Risk Score; hs-CRP, high-sensitivity C-reactive protein; hs-TnT, high-sensitivity; LV, left ventricle.
Note that all correlations are additionally adjusted for age, gender and follow-up time.